A5014636066- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Liver Disease and Transplantation
- Antiplatelet Therapy and Cardiovascular Diseases
- Liver Disease Diagnosis and Treatment
- Palliative Care and End-of-Life Issues
- Coronary Interventions and Diagnostics
- Hepatitis Viruses Studies and Epidemiology
- Maternal and fetal healthcare
- Pregnancy and preeclampsia studies
- Prenatal Screening and Diagnostics
- Blood Coagulation and Thrombosis Mechanisms
- Ectopic Pregnancy Diagnosis and Management
- Hepatitis C virus research
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Issues in Pregnancy
- Frailty in Older Adults
- Thyroid Disorders and Treatments
- Hormonal and reproductive studies
- Myasthenia Gravis and Thymoma
- Reproductive Health and Contraception
- Case Reports on Hematomas
- Central Venous Catheters and Hemodialysis
- Blood Pressure and Hypertension Studies
- Family and Patient Care in Intensive Care Units
University of Insubria
2015-2021
Weatherford College
2015
Fondazione Audiologica Varese
2014
What evaluation and care is offered to women after unexplained recurrent pregnancy loss (RPL) or intra-uterine foetal death (IUFD) what are the reproductive outcomes?Women assessed for thrombophilia often treated with low-molecular weight heparin (LMWH) and/or low-dose aspirin (ASA).Randomized controlled trials (RCTs) on possible efficacy of heparins have been inconclusive due limited power detect a difference patient heterogeneity.Prospective multicentre cohort study performed in 12...
Spontaneous pregnancy loss and implantation failure after assisted reproductive technologies (ART) are very common occurrences. Although 50–60% of all cases remains unexplained, various predisposing factors, including thrombophilias, have been identified. Thus, the potential benefit a prophylaxis with low-molecular-weight heparins in improving outcomes has often investigated over years. However, majority studies observational results from randomized clinical trials (RCTs) inconclusive,...
Chronic liver disease may predispose patients to thrombotic events for local risk factors, such as portal hypertension and consequent venous stasis, which can lead vein thrombosis (1). Moreover, the delicate haemostatic balance between reduced production of procoagulant factors decreased levels anticoagulants (such protein C antithrombin) (2)